- Home
- STVN
as of 09-03-2026 3:38pm EST
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
| Founded: | 1949 | Country: | Italy |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.9B | IPO Year: | 2021 |
| Target Price: | $25.67 | AVG Volume (30 days): | 413.4K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $12.89 - $28.00 | Next Earning Date: | 05-07-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 9.67% | Revenue Growth (next year): | 9.99% |
| P/E Ratio: | 27.15 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
AI-Powered STVN Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Stevanato Group S.p.A. (STVN)
Director
Avg Cost/Share
$20.09
Shares
2,023
Total Value
$40,642.07
Owned After
4,739
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$20.09
Shares
4,209
Total Value
$84,558.81
Owned After
81,144
SEC Form 4
Director
Avg Cost/Share
$20.09
Shares
2,045
Total Value
$41,084.05
Owned After
2,930
SEC Form 4
Director
Avg Cost/Share
$17.09
Shares
1,493
Total Value
$25,515.37
Owned After
5,757
SEC Form 4
Director
Avg Cost/Share
$17.09
Shares
1,493
Total Value
$25,515.37
Owned After
69,458
SEC Form 4
Director
Avg Cost/Share
$17.09
Shares
1,493
Total Value
$25,515.37
Owned After
37,424
SEC Form 4
Director
Avg Cost/Share
$17.09
Shares
1,493
Total Value
$25,515.37
Owned After
26,991
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Santel Luciano | STVN | Director | Aug 7, 2026 | Sell | $20.09 | 2,023 | $40,642.07 | 4,739 | |
| Dal Lago Marco | STVN | Chief Financial Officer | Aug 7, 2026 | Sell | $20.09 | 4,209 | $84,558.81 | 81,144 | |
| Magistretti Elisabetta | STVN | Director | Aug 7, 2026 | Sell | $20.09 | 2,045 | $41,084.05 | 2,930 | |
| Flynn Karen | STVN | Director | Jun 15, 2026 | Sell | $17.09 | 1,493 | $25,515.37 | 5,757 | |
| Balachandran Madhavan | STVN | Director | Jun 15, 2026 | Sell | $17.09 | 1,493 | $25,515.37 | 69,458 | |
| MOREL DONALD E JR | STVN | Director | Jun 15, 2026 | Sell | $17.09 | 1,493 | $25,515.37 | 37,424 | |
| FEDERICI WILLIAM J | STVN | Director | Jun 15, 2026 | Sell | $17.09 | 1,493 | $25,515.37 | 26,991 |
Compare STVN vs Leading Stocks
See how STVN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "STVN Stevanato Group S.p.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.